The Biden administration pretends at the moment that they want to create a new organization that works like Darpa and that's more open to innovation the way Darpa is more open to innovation. The announcement reads:
Launch the Advanced Research Projects Agency for Health (ARPA-H). The discretionary request calls for $6.5 billion to launch the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health (NIH). With an initial focus on cancer and other diseases such as diabetes and Alzheimer’s, this major investment in federal research and development will drive transformational innovation in health research and speed application and implementation of health breakthroughs.
Part of what makes Darpa special that it's not told by politicians to focus on the problems that are most obvious to the politicians but is more free about chosing politicians. Focus on Cancer/Diabetes/Alzheimer's suggest that's not the case here as those are the traditional targets of NIH funding anyway. Does anybody have a more optimistic take on the annoucement and expect it to actually produce an organization that's comparable to DARPA?
When DARPA was founded it was explicitly under political authority. "The Agency shall be responsible for the direction or performance of such advanced projects in the field of research and development as the Secretary of Defense shall, from time to time, designate by individual project or by category." Its initial focus was on space technology, ballistic missile defence, and solid propellants, all of them things that politicians were concerned about because of Russia's recent success in the space race. (Much of that stuff got moved over to NASA when that was founded shortly afterwards.)
Is there anything that specifically suggests that ARPA-H will be more politician-driven than DARPA?
That seemed like the objection is more, it's going to be a slave to the existing orthodoxy as far as what's important/promising, rather than the politians, and the former is even worse if you're expecting novel thought or research directions. Not sure to what extent that's actually true but reporting structure does matter; especially the topmost layer that still has strong technical opinions.